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Clinical significance of costimulatory molecules CD80/CD86
expression in IgA nephropathy.
Background. IgA nephropathy (IgAN) is the most common
form of human glomerulonephritis. Tubulointerstitial inflam-
mation with infiltration of mononuclear cells plays an important
role in the progression of IgAN. Activation of T cells requires
costimulatory signals through binding of CD28 receptor with
cognate ligands (CD80/CD86) located on antigen-presenting
cells (APC). To assess the clinical significance of this regulatory
pathway participation in the pathogenesis of IgAN, a compre-
hensive immunohistologic evaluation was conducted on renal
tissue of IgAN in different phases of progressive injury.
Methods. Thirty-three cases of IgAN and ten cases of non-
IgA mesangial proliferative glomerulonephritis (PGN) with mi-
nor tissue damage as controls were investigated. Monoclonal
antibodies were used to assess the expression of CD80, CD86,
CD68, CD14, CD45RO, human leukocyte antigen-DR (HLA-
DR), and intercellular adhesion molecule-1 (ICAM-1) in renal
tissues. Clinical and expression data were compared at the time
of renal biopsy.
Results. CD80+ and CD86+ cells were observed more in
IgAN patients with progressive renal injury than in mild cases
and controls. CD80 was limited to tubular epithelial cells and
was complemented by HLA-DR expression. CD86 was ex-
pressed in the glomerulus, periglomerular area, and peritubu-
lar interstitium. Activated T cells (CD45RO+), monocytes
(CD14+), macrophages (CD68+), and CD86 showed similar
distributions. Positive correlations were found between CD86+
cells and CD45RO, CD14, and CD68 positive cells and between
CD80+ tubuli and peritubular interstitial CD45RO+ cells. The
number of interstitial CD86 positive cells and the percentage
of CD80+ tubuli were correlated with renal function. Most
CD86+ cells were monocyte/macrophages.
Conclusion. This study suggested that CD80 and CD86 ac-
tivate T cells in IgAN, CD80/CD86 expressions correlated
with renal function at the time of renal biopsy, and mono-
cyte/macrophages and tubular epithelial cells act as APC.
IgA nephropathy (IgAN) is known as a form of chronic
glomerulonephritis mediated by IgA immune complexes
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and characterized by predominant mesangial IgA de-
posits, mesangial cell proliferation and mesangial ma-
trix expansion. The prognosis of IgAN is not particularly
good. The renal survival of adults at 10 years is between
81% and 87% [1]. According to recent studies, serum
creatinine levels at the time of renal biopsy, amount of
proteinuria, blood pressure, and the degree of glomeru-
lar and tubulointerstitial lesions were shown to be closely
correlated with the prognosis of IgAN [1–5]. Glomeru-
lar and tubulointerstitial cell infiltration is involved in
the tissue destruction and therefore in renal dysfunction.
The infiltrating cells in renal tissues are mostly T lym-
phocytes and monocyte/macrophages [6, 7]. To activate
T cells requires not only the peptide/major histocompati-
bility complex (MHC) class II on antigen-presenting cells
(APC), but also second or costimulatory molecules pro-
vided by APC. Without costimulation when antigen is
presented, T cells fall into clonal anergy [8]. Intercellu-
lar adhesion molecule-1 (ICAM-1) (CD54), one of the
costimulatory molecules, was studied by several investi-
gators and found to be involved in the recruitment of
leukocytes in IgAN [9, 10]. Several basic studies demon-
strated that CD80 (B7-1) and CD86 (B7-2) are the most
important costimulatory molecules. They are found only
on APC such as dendritic cells, activated B cells, and
macrophages [8, 11]. Their expression can be induced
rapidly on APC after encountering various stimuli [11–
14]. CD80 and CD86 on APC may either activate T cells
by binding to CD28 receptor or may inactivate these cells
by binding to the cytotoxic T lymphocyte-associated anti-
gen (CTLA-4) receptor.
Murine lupus models treated with CD80/CD86 block-
ing antibodies or those mutants that are deficient in
CD80/CD86 had decreased autoantibody levels. They did
not develop or had only mild kidney pathology and sur-
vived far longer [15, 16].
The relationship between CD80/CD86 molecules and
human glomerulonephritis is unknown. In this study,
we investigated the expression of CD80/CD86 in hu-
man IgAN renal tissues and analyzed the correla-
tion between the CD80/CD86-positive cells and renal
function.
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METHODS
Patients
Remnant tissue from open renal biopsy specimens ob-
tained from 33 patients who were diagnosed as having
IgAN by clinical and histopathologic examinations were
used in this study.
The histopathologic changes were divided into four
grades, from grade 1 to grade 4 (mild to severe tissue
damage), according to the degree and extent of glomeru-
lar, tubulointerstitial, and vascular lesions observed by
light microscopy [17]. Three patients belonged in grade 1.
The other 30 patients belonged in grade 2 to grade 4 with
ten patients in each grade. Ten biopsy specimens from
patients with non-IgA mesangial proliferative glomeru-
lonephritis (PGN) with minor tissue damage were used
as a control.
Clinical parameters at the time of renal biopsy an-
alyzed in this study included age, gender, duration of
illness, systolic blood pressure, diastolic blood pressure,
total serum protein level, serum albumin level, serum
urea nitrogen concentration, serum creatinine concentra-
tion, creatinine clearance, amount of 24-hour proteinuria,
degree of hematuria, and serum IgA concentration.
Immunoperoxidase staining
All renal tissues were frozen in 22-oxacalcitriol (OCT)
compound in dry ice-acetone and stored at −80◦C until
the study. Serial and mirror sections at 4 lm were pre-
pared, air-dried for 30 minutes, and then fixed with 100%
acetone at 4◦C for 10 minutes. After preincubation with
10% normal goat serum in phosphate-buffered saline
(PBS)/1% bovine serum albumin (BSA) at room tem-
perature for 20 minutes, sections were incubated with pri-
mary antibodies at the optimal dilution overnight at 4◦C.
Endogenous peroxidase activity was blocked by 0.03%
hydrogen peroxide in methanol for 30 minutes. Then the
sections were incubated with the second antibody, En-
vision+TM (Dako, Tokyo, Japan), for 30 minutes. Slides
were rinsed in PBS after each step. Reaction products
were developed with 3, 3′-diaminobenzidine (DAB). Af-
ter staining with periodic acid-Schiff solution (PAS) and
counterstaining with Mayer’s hematoxylin, slides were
mounted for light microscopic examination.
The primary antibodies were CD80 (BB1) (Southern
Biotechnology Associates, Inc., Birmingham, AL, USA),
CD86 (BU63) (Cosmo Bio, Tokyo, Japan), CD45RO
(UCHL-1) (Dako), CD68 (PGM-1) (Dako), CD14
(TU¨K4) (Dako), ICAM-1 (6.5B5) (Dako), and HLA-DR
(TAL.1B5) (Dako).
Analysis of CD80 and CD86 expression in vitro
Reverse transcription-polymerase chain reaction (RT-
PCR). Human proximal tubular epithelial cells (HKC-
8) were kindly provided by Dr. L. Racusen of John
Hopkins University (Baltimore, MD, USA). Cells
were cultured in Dulbecco’s modified Eagle’s medium
(DMEM)-F12 medium supplemented with 5% fetal
bovine serum (FBS) (Life Technologies, Inc., Grand Is-
land, NY, USA). For the treatment of cytokines, HKC
cells were seeded at proximately 60% confluence in
35 mm dishes in the complete media containing 5% FBS
for 24 hours and then underwent serum starvation for an-
other 24 hours. Human recombinant interferon (INF)-c
and lipopolysaccharide (LPS) were added to the culture
with fresh serum-free medium at a final concentration of
300 IU/mL and 12.5 lg/mL, respectively.
At time 0, 12, 24, and 48 hours, the media was removed
and the total RNA was extracted using TRIzol solution
according to the instructions specified by the manufac-
turer. Briefly, cells were harvested in TRIzol and 200 lL
chloroform was added. After centrifugation for 15 min-
utes at 12,000g, the aqueous phase was mixed with an
equal volume of isopropyl alcohol. After 12 hours at
−20◦C, the RNA was pelleted for 15 minutes at 10,000g,
washed twice with 70% ethanol, dried, and redissolved in
H2O. RNA was quantified by ultraviolet absorbance mea-
surements at 260nm. Preparation of cDNA, from 2 lg
of total RNA, was carried out as previously described
by Yano et al [18]. The cDNA prepared from each
specimen was subjected to 35 cycles in a final vol-
ume of 25 lL using the following primers: CD80 (PCR
product 238 bp) forward GGGAAAGTGTACGCCCT
GTA and reverse TGCATATGGGGAGAAAGGAG;
CD86 (PCR product 217 bp) forward TGGAACCAACA
CAATGGAGA and reverse AAAAAGGTTGCCCA
GGAACT; and glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) (PCR product 473 bp) forward TGGGT
GTGAACCATGAGAAG and reverse GGTGTCGC
TGTTGAAGTCAG. The PCR products were elec-
trophoresed in agarose gels, stained with ethidium bro-
mide and photographed using instant Polaroid 667 film.
Flow cytometry. Serum-deprived quiescent HKC
cells were treated with LPS (12.5 lg/mL) and IFN-c (300
units). Cells were harvested at 12, 24, and 48 hours. Cells
were detached from the flask with 0.02% ethylenedi-
aminetetraacetic acid (EDTA). The cells were then cen-
trifuged at 500g for 5 minutes and washed twice with PBS
containing 0.5% BSA. Cell pellet was resuspended in 200
mL PBS/0.5%BSA and 20 lL of fluorescent-conjugated
monoclonal antibody (eBioscience, San Diego, CA,
USA): Fluorescein antihuman MHC I (IgG2a, clone
W6/32), phycoerythrin antihuman CD80 (IgG1, clone
2D10.4), or phycoerythrin antihuman CD86 (IgG2b,
clone IT2.2). Cells were incubated in the dark for 40 min-
utes. Then the cells were washed once in PBS/0.5%BSA,
fixed in 200 mL of 0.5% paraformaldehyde, and aliquot
of the cells were fixed in 0.5% paraformaldehyde and
then analyzed for the presence of fluorescent-labeled
donor cells using a flow cytometer (FACScan, Becton-
Dickinson, San Jose, CA, USA).
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Scoring technique
Intraglomerular, periglomerular, and peritubular in-
terstitial CD86, CD45RO, CD68, and CD14 positive cells
were counted. All glomeruli except for sclerotic ones in
the sections were calculated and intraglomerular CD86,
CD45RO, CD68, and CD14 positive cells were assessed
as the number of cells per glomerular cross-section;
periglomerular positive cells were assessed as the num-
ber of cells per periglomerular area. Peritubular inter-
stitial positive cells were counted using an eyepiece with
calibrated reticle grid in at least 20 interstitial fields (mag-
nification 400×) and the results were expressed as the
number of cells per 0.0625 mm2. The number of CD80+
tubuli was counted and the results were expressed as
percentage of positive tubuli. Periglomerular area was
defined as the area between Bowman’s capsule and ad-
jacent tubules. Mesangial proliferation was graded from
0 to 3 (0, no proliferation; 1, mild; 2, middle; and 3, se-
vere proliferation) and the average proliferation grade
was calculated. The evaluation of glomerular tuft adhe-
sion and crescent formation were decided as percentage
of glomeruli presenting adhesion or crescent.
Statistical analysis
The Kruskal-Wallis test, Bonferroni’s multiple compar-
ison analysis, Pearson’s correlation analysis and paired-
sample t test were employed in this study using SPSS
software. The Kruskal-Wallis test and Bonferroni’s mul-
tiple comparison were used to compare clinical differ-
ences and differences in numbers of intraglomerular,
periglomerular, and peritubular interstitial-positive cells
among IgAN grade 1 to grade 4 and PGN. The level of
significance was set at P < 0.005 based on Bonferroni’s
multiple comparison. P < 0.05 was considered significant
in other analysis.
RESULTS
Clinical data
The clinical data of IgAN and PGN patients at the
time of renal biopsy are presented in Table 1. Values are
expressed as means ± SD. The PGN were selected as
controls because the patients who had kidney carcinoma
were of advanced age and their uninvolved portions of re-
moved kidneys had global glomerulosclerosis with tubu-
lointerstitial damage. IgAN grade 4 patients had greater
renal dysfunction as compared with other groups. The
significance among IgAN groups and PGN is shown in
Table 1. We failed to find any statistically significant dif-
ferences between IgAN grade 1 and other groups because
of the small number of patients with IgAN grade 1.
Expression of CD80 in renal tissues
The expression and distribution patterns of CD80
and CD86 were different in IgAN patients. CD80 was
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Fig. 1. In serial sections, some tubular epithelial cells expressed CD80 molecule (A) the human leukocyte antigen-DR (HLA-DR) molecule (B)
simultaneously (original magnification ×200).
expressed in some tubular epithelial cells (Fig. 1A),
with dwindling tubuli (which had mild thickened or
winding basement membrane in PAS staining) showing
especially strong CD80 staining. However, completely at-
rophic tubuli (which had marked thickened or thinned
and sometimes broken basement membrane in PAS stain-
ing) showed no CD80 expression.
In renal biopsies, many CD14+, CD68+, and
CD45RO+ cells were found surrounding these tubuli.
Some tubuli without surrounding infiltrating cells also
expressed CD80, even in PGN and IgAN grade 1. Ex-
cept for one or two CD80+ cells in the interstitium in
some sections, which may be B cells according to the
difference in number of infiltrating cell types in IgAN
[6], no intraglomerular, periglomerular, or peritubular
interstitial CD80 expression was observed. The percent-
age of CD80+ tubuli were increased in IgAN grade 3
and grade 4 compared with PGN and increased in IgAN
grade 4 compared with grade 2 (Fig. 2A). Positive cor-
relation was also demonstrated between the percentage
of CD80+ tubuli and the number of peritubular inter-
stitial CD45RO+ T cells (Table 2). No correlation was
found between these two values in PGN (R = −0.288,
P = 0.420). Positive correlations were found between
tubular CD80 expression and mesangial proliferation
(R = 0.506, P = 0.003), tuft adhesion (R = 0.408, P =
0.019), and crescent formation (R = 0.483, P = 0.005).
CD80 and HLA-DR staining were done in serial sec-
tions. As shown in Figure 1, some dwindling tubuli ex-
pressed both CD80 and HLA-DR. In addition, some
CD80+ tubular epithelial cells expressed ICAM-1. How-
ever, most of the CD80+ cells were HLA-DR and ICAM-
1 negative.
Expression of CD86 in renal tissues
CD86 was expressed in the glomerulus, periglomerular
area, perivascular interstitium, and peritubular intersti-
tium (Fig. 3A). Tubular epithelial cells were negative for
CD86 (Fig. 3A).
In renal biopsies, the intraglomerular CD86+ cells
were found mainly in the capillaries. They were also
present at the site of adhesion to Bowman’s capsules and
in some cellular crescents with intense staining in the cor-
responding periglomerular areas (Fig. 3B and C). In the
early stage of glomerulonephritis, such as in IgAN grade
1, grade 2 and PGN patients, only a few CD86+ cells were
present in the glomerulus, periglomerular area, or dis-
persed in the peritubular interstitium. In the later stage,
such as in IgAN grade 3 and grade 4, increased intra-
glomerular, periglomerular, and peritubular interstitial
CD86+ cells were found when compared with grade 2
and PGN. Also in IgAN grade 3 and grade 4 patients
many CD86+ cells were observed at the site of cell in-
filtration whereby CD45RO, CD14, and CD68 showed
similar distribution to that of CD86. Despite overlapping
expression, there were few differences between CD14
and CD68 codistribution. More CD68+ cells were found
in glomerulus than CD14+ cells (P < 0.001). The num-
ber of intraglomerular, periglomerular, and peritubular
interstitial CD86, CD45RO, CD68, and CD14 positive
cells in IgAN grade 1 to grade 4 and PGN are shown in
graphic form in Figure 2B to D and P values of less than
0.005 are shown in tables beside the graphs.
Intraglomerular, periglomerular, and peritubular in-
terstitial CD14+ cells and CD68+ cells showed close
correlation with corresponding CD45RO+ cells (data
not shown). Positive correlation was observed between
the numbers of intraglomerular, periglomerular, and per-
itubular interstitial CD86+ cells and the correspond-
ing CD45RO+ cells, CD68+ cells, and CD14+ cells
(Table 2).
Interstitial CD14+ cells were mostly restricted to
within the capillaries while CD68+ cells found mainly
in areas of CD45RO+ cell infiltration (no statisti-
cal significance). Monocytes/macrophages are known as
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Fig. 2. Comparisons of IgA nephropahy
(IgAN) and proliferative glomerulonephritis
(PGN) tissues. (A) The positive percentage
of tubular CD80 expression in IgAN grade
1 to 4 and PGN tissues. (B) The numbers
of intraglomerular CD86, CD45RO, CD68,
and CD14 positive cells in IgAN grade 1
to 4 and PGN tissues. (C) The numbers of
periglomerular CD86, CD45RO, CD68, and
CD14 positive cells in IgAN grade 1 to 4 and
PGN tissues. (D) The numbers of peritubular
interstitial CD86, CD45RO, CD68 and CD14
positive cells in IgAN grade 1 to 4 and PGN
tissues.
Table 2. Correlations between CD80/CD86+ values and
corresponding CD45RO, CD68, and CD14+ cell numbers in IgA
nephropathy (IgAN)
CD45RO CD68 CD14
Intraglomerular CD86 0.698 0.905 0.931
Periglomerular CD86 0.879 0.823 0.835
Peritubular interstitial CD86 0.847 0.849 0.803
Tubular CD80+ percentage 0.660a
aCorrelation between tubular CD80+ percentage and the number of
peritubular interstitial CD45RO+ cells.
P values of all correlations in the table were less than 0.001.
professional APC. In order to identify whether CD86+
cells are monocytes/macrophages, we used mirror tis-
sue sections and paired antibodies to stain for either
CD86/CD14 or CD86/CD68. We found that the most
(more than 60%) intraglomerular CD86+ cells were
CD68+ (Fig. 3D and E) and some (less than 40%) were
CD14+. Most periglomerular CD86+ cells were also
CD68+ (Fig. 3F and G) and some were CD14+.
Many interstitial CD86+ cells were observed in the
presence of activated T cells. These CD86 expressing cells
were identified mainly as CD68+ cells but not CD14+
cells (Fig. 3H to J). Some CD86+ cells were not mono-
cyte/macrophages because of negative staining for CD14
and CD68. Some CD14+ or CD68+ cells did not express
the CD86 molecule. Regardless, the number of CD86+
cells tended to increase from IgAN grade 1 to grade 4.
Expression of CD80 and CD86 in vitro
The expression of CD80 mRNA in quiescent and LPS
and INF-c activated cultured proximal tubular epithelial
cells (PTEC) was examined by RT-PCR. As presented in
Figure 4, quiescent cells showed little or no CD80 expres-
sion. In contrast, activated PTEC showed up-regulated
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Fig. 3. Expression of the CD86 molecule. (A) The expression of CD86 molecule in glomerulus, periglomerular area and peritubular interstitium
(original magnification ×100). (B) Original magnification ×400 and (C) original magnification ×200 show the expression of CD86 in adhesion
to Bowman’s capsule and crescent. Immunostaining of monoclonal antibodies in mirror sections show that in glomerulus, most CD86+ cells (D)
expressed the CD68 molecule (E) and some periglomerular cells expressed both CD86 (F) and CD68 (G) molecules (original magnification ×200).
In the peritubular interstitium with mainly local infiltrating cells, CD86 expressing cells (H) were almost all CD68+ cells (I) but not CD14+ cells
(J) (H) and (I) are mirror sections. (H) and (J) are serial sections) (original magnification ×200).
expression between 12 and 24 hours after stimulation and
relatively subsided after 48 hours. There was no evidence
for induction or up-regulated expression of CD86 in the
human PTEC (data not shown). The expression of CD80
protein was examined by flow cytometry. Consistent with
the above, only fewer quiescent PTEC showed a low level
of CD80 expression. While given the stimulation of LPS
and INF-c, the number of PTEC with CD80 expression
was increased and showed a peak level at 12 hours and
sustained to be detected until 48 hours (Fig. 5).
Clinical significance of CD80 and CD86 expression
We used Pearson’s correlation analysis to investigate
correlation between the number of CD86+ cells and re-
nal function at the time of biopsy (Table 3). The number
of interstitial CD86+ cells showed a positive correlation
with blood urea nitrogen (BUN) and serum creatinine
and a negative correlation with creatinine clearance. A
negative correlation was also seen between the number
of periglomerular CD86+ cells and creatinine clearance.
The percentage of CD80+ tubuli showed a positive cor-
relation with serum creatinine and a negative correlation
with creatinine clearance. Peritubular interstitial CD14,
CD68, and CD45RO+ cells and periglomerular CD68+
cells had positive correlations with BUN and serum cre-
atinine, while both periglomerular and peritubular inter-
stitial CD14, CD68, and CD45RO+ cells had negative
correlation with creatinine clearance (data not shown).
DISCUSSION
It is well established that the “two-signal” model of
T lymphocyte activation was proposed to explain the
distinction between self and nonself. According to this
model specific binding of the T-cell receptor to anti-
gen/MHC class II complex requires a second signal con-
veyed through the simultaneous binding of costimulatory
molecules on APC. CD80 and CD86 are the most charac-
terized costimulatory molecules for T-cell activation [8].
In this study, we found that both of these molecules are
associated with renal tissue damage of IgAN. CD86 was
expressed extensively in the glomerulus, periglomerular
area, and peritubular interstitium, while CD80 was ex-
pressed only on tubular epithelial cells. This feature was
also observed in human crescentic glomerulonephritis
[19]. Activated T cells (CD45RO+ cells) also distributed
in the glomerulus, periglomerular area, and peritubular
interstitium in a parallel pattern. Moreover, the num-
ber of CD86+ cells in the glomerulus, periglomerular
area, and peritubular interstitium were increased with
the progress of renal tissue damage and these CD86+
cells showed strong positive correlation with the num-
ber of CD45RO T cells in the same areas. The CD80+
tubular expression also showed a tendency to increase
with tissue damage and was correlated with the number
of peritubular interstitial CD45RO T cells.
Experimental evidence has demonstrated that binding
or deficiency in CD80/CD86 molecules can inhibit ac-
tivation of T cells. Impaired spleen T-cell proliferation
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Fig. 4. Representative expression of CD80 induction in proximal tubu-
lar epithelial cells (PTEC) stimulated with interferon-gamma (IFN-c)
(300 IU) and lipopolysaccharide (LPS) (12.5 lg). Ethidium bromide-
stained agarose gel containing 35 cycles amplified polymerase chain
reaction (PCR) products of C80 (upper panel) and corresponding
glyeraldehyde-3-phosphate dehydrogenase (GAPDH) (lower panel) of
each sample. Left lane [molecular weight (MW)] is standardφX174 RF
DNA/HaeIII. The Polaroid 667 photograph was reverse-scanned.
was described in a murine Sjo¨gren’s syndrome model
treated with anti-CD86 monoclonal antibody [20] and in
a murine experimental autoimmune uveoretinitis (EAU)
model treated with anti-CD80 monoclonal antibody [21].
In experimental lupus nephritis, CD80/CD86-deficient
mice had decreased T-cell numbers in the glomerulus,
periglomerular area, and peritubular interstitium com-
pared with controls [15]. Consistent with these experi-
mental observations are our clinical findings that CD80
and CD86 molecules are also associated with the acti-
vated T cells in human IgAN.
CD80 and CD86 are cell surface glycoproteins with
similar structures that belong to the immunoglobulin su-
perfamily and are members of the B7 family [8]. CD80
is expressed at low levels on resting monocytes and
dendritic cells but not on resting B cells. CD86 is ex-
pressed more on resting monocytes and dendritic cells
but not on resting B cells. Their expressions can be
induced to high levels on activated B cells, activated
macrophages, and dendritic cells [13, 14]. Most CD86+
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Fig. 5. Flow cytometry of CD80 molecule expression in proximal tubu-
lar epithelial cells (PTEC). Few PTEC showed CD80 expression on
unstimulated state (0 hours). When stimulated with interferon-gamma
(IFN-c) (300 IU) and lipopolysaccharide (LPS) (12.5 lg), the number
of PTEC with CD80 expression was increased with a peak level at 12
hours and sustained until 48 hours.
cells in IgAN renal tissues were monocyte/macrophages.
In our study, the CD80 molecule was not expressed on
monocytes and macrophages. This might due to the need
for both CD80 and CD86 when antigens are presented
to the immune system [22]. Cholera toxin enhanced mu-
cosal immune response by up-regulating CD86 but not
CD80 expression on bone marrow macrophages [23].
The expression of costimulatory molecule CD86 alone on
monocyte/macrophages may due to the properties of the
pathogen. Alternatively, the monoclonal antibody could
not recognize the CD80 epitope on macrophages. Recent
investigations suggest that activated macrophages with
CD80/CD86 expression in the blood lymphocyte pool and
peripheral tissues can directly activate naive T cells [24].
Our results demonstrate that CD14+ and CD68+ cells
showed strong correlation with CD45RO T cells in the
glomerulus, periglomerular area, and peritubular inter-
stitium. These findings also suggest that monocytes and
macrophages, especially CD68+ macrophages, may not
only contribute to T-cell activation but may also cause
T-cell proliferation via the CD28-CD86 pathway in areas
of local infiltration.
Tubular epithelial cells are known as very active cells
that play an important role in the pathogenesis and pro-
gression of renal disease. They can produce a wide vari-
ety of inflammatory mediators, including cytokines [25,
26] and chemokines, such as monocyte chemoattractant
protein-1 (MCP-1), MCP-4. and osteopontin [27–29]. Re-
cent studies suggest epithelial cells may also function
as APC in the pathogenesis of nephritis. Costimulatory
molecule ICAM-1 expression was reported for tubular
epithelial cells [9, 10]. Experimentally, CD80 expres-
sion was demonstrated in murine cultured renal tubu-
lar epithelial cells as well as in renal tissue [30]. Tubular
CD80 expression was also observed in human crescen-
tic glomerulonephritis [19]. In this study, we presented
concordant confirmatory in vitro evidence document-
ing the up-regulated expression of CD80 on LPS/IFN-c-
activated but not quiescent human PTEC. These findings
Wu et al: CD80 and CD86 in IgA nephropathy 895
Table 3. Correlations between CD80/CD86+ values and renal function of IgA nephropathy (IgAN) patients
Intraglomerular CD86 Periglomerular CD86 Peritubular Interstitial CD86 CD80
R P value R P value R P value R P value
Blood urea nitrogen 0.068 0.706 0.336 0.056 0.674 0.000 0.281 0.113
Serum creatinine 0.153 0.395 0.295 0.096 0.747 0.000 0.350 0.046
Creatinine clearance −0.204 0.254 −0.458 0.007 −0.510 0.002 −0.400 0.021
are also consistent with very recent reports demonstrat-
ing the expression of CD80 on cytokine or complement-
activated tubular epithelial cells [31, 32]. However, we
found extensive CD80 expression more than ICAM-1 and
HLA-DR expression in tubular epithelial cells in the dis-
eased human renal tissues. It was noted that dwindling
tubular epithelial cells surrounded by a large number of
infiltrating leukocytes showed strong expression of CD80
and some of them expressed HLA-DR simultaneously.
The percentage of CD80+ tubuli had a positive correla-
tion with the number of peritubular interstitial activated
T cells (CD45RO+). Thus, the results suggest that tubu-
lar epithelial cells, especially dwindling tubular cells, may
play an APC role in activation of peritubular interstitial
T cells. It should be noted that some tubular epithelial
cells expressed CD80 with no or only a few adjacent
CD45RO T cells present. Accordingly, the appearance
of CD80 earlier than that of ICAM-1 and HLA-DR sug-
gests tubular epithelial cells at the early stage of renal
disease acquire the potential APC phenotype that is com-
plemented later by the HLA-DR expression. The posi-
tive correlations between tubular CD80 expression and
mesangial proliferation, tuft adhesion, and crescent for-
mation indicate that the stimulatory factors that induce
tubular CD80 expression may be originated from dam-
aged glomerulus and flow into the tubular lumen.
The relationship between the peritubular interstitial
activated T cells and the periglomerular, peritubular in-
terstitial CD86+ monocyte/macrophages, and CD80+
tubuli indicates that both monocyte/macrophages and
tubuli contributed to the activation of interstitial T cells.
It is known that T cells can also activate macrophages
through the release of various cytokines [33] and destroy
tubular epithelial cells with these macrophages by secret-
ing various cytokines or by other mechanisms and could
further activate tubular epithelial cells [34] and interstitial
fibroblasts [33]. In IgAN kidney, we found that with the
increase of interstitial infiltrating T cells, the number of
monocyte/macrophages, and CD80+ tubuli all increased.
Some of these monocyte/macrophages, especially those in
the interstitium, showed no CD86 expression, and those
cells may be activated by T cells. These dwindling tubu-
lar epithelial cells showed strong CD80 and HLA-DR
expression and were surrounded by a large number of
macrophages and activated T cells; some completely at-
rophic tubuli were found within this infiltrating cell mass.
These findings suggest that the interaction of tubular ep-
ithelial cells and infiltrating leukocytes cause tubulointer-
stitial injury, which coincides with the results of previous
investigations [6, 7]. In IgAN kidney, intraglomerular and
periglomerular monocyte/macrophages and activated
T cells were found even in grade 1 and their numbers
increased from grade 2 to grade 4, especially in glomeru-
lus with adhesion to Bowman’ capsule and/or crescent
formation. With the increase in the number of interstitial
mononuclear cells, the number of intraglomerular and
periglomerular infiltrating monocyte/macrophages and
activated T cells also increased, suggesting an important
role for these infiltrating mononuclear cells in glomerular
damage and a relationship between glomerular damage
and tubulointerstitial lesions. The tubular injury caused
by glomerular damage maybe due to the cytokines and
growth factors produced by intrinsic glomerular cells
and intraglomerular leukocytes and the proteins entering
the tubular lumen [33]. However, intraglomerular mono-
cyte/macrophages and activated T cells could not predict
the prognosis of IgAN patients because no correlation
was found between these cells and the renal function at
the time of renal biopsy. On the other hand, interstitial in-
filtrating mononuclear cells and the tubular CD80+ value
showed a positive correlation with the renal function at
the time of renal biopsy. All these findings suggest that
the vicious circle of leukocyte activation among glomeru-
lar and tubular damage is one possible reason for renal
dysfunction and support the view that tubulointerstitial
lesions determine the prognosis of IgAN [6, 7, 10, 18, 35,
36].
CONCLUSION
Our findings suggest that costimulatory molecules
CD80 and CD86 are involved in the activation of T cells
in IgAN; monocyte/macrophages are the major APC that
express the CD86 molecule to activate T cells; tubular ep-
ithelial cells can express the CD80 molecule and may play
an early role in activating interstitial T cells; and the ex-
pression of CD80/CD86 molecules is related to the renal
function at the time of renal biopsy.
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